Temporal trends and socioeconomic determinants of cytoreductive nephrectomy (CN) utilization for metastatic renal cell carcinoma (mRCC) in the United States (US).

被引：0
|
作者：
Esagian, Stepan M.
Msaouel, Pavlos
Karam, Jose A.
Gartrell, Benjamin
Makrakis, Dimitrios
机构：
[1] Albert Einstein Coll Med, NYC Hlth Hosp Jacobi, Dept Med, Bronx, NY USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Houston, TX USA
[3] Univ Texas MD Anderson Canc Ctr, Houston, TX USA
[4] Montefiore Einstein Canc Ctr, Bronx, NY USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2025年 / 43卷 / 5_SUPPL期
关键词：
D O I：
10.1200/JCO.2025.43.5_suppl.447
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [21] A Population-based Analysis of the Rate of Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma in the United States
    Jeldres, Claudio
    Baillargeon-Gagne, Sara
    Liberman, Daniel
    Isbarn, Hendrik
    Capitanio, Umberto
    Shariat, Shahrokh F.
    Sun, Maxine
    Lughezzani, Giovanni
    Perrotte, Paul
    Montorsi, Francesco
    Graefen, Markus
    Karakiewicz, Pierre I.
    UROLOGY, 2009, 74 (04) : 837 - 841
  • [22] Cytoreductive nephrectomy for metastatic renal cell carcinoma in the era of targeted therapy in the United States: a SEER analysis
    Che-kai Tsao
    Alexander C. Small
    Max Kates
    Erin L. Moshier
    Juan P. Wisnivesky
    Benjamin A. Gartrell
    Guru Sonpavde
    James H. Godbold
    Michael A. Palese
    Simon J. Hall
    William K. Oh
    Matthew D. Galsky
    World Journal of Urology, 2013, 31 : 1535 - 1539
  • [23] The Impact of Targeted Therapy on Management of Metastatic Renal Cell Carcinoma: Trends in Systemic Therapy and Cytoreductive Nephrectomy Utilization
    Psutka, Sarah P.
    Kim, Simon P.
    Gross, Cary P.
    Van Houten, Holly
    Thompson, R. Houston
    Abouassaly, Robert
    Weight, Christopher
    Boorjian, Stephen A.
    Leibovich, Bradley C.
    Shah, Nilay D.
    UROLOGY, 2015, 85 (02) : 442 - 450
  • [24] Association of primary tumor radiomic phenotypes and outcomes in patients (pts) with metastatic renal cell clear cell carcinoma (mRCC) treated with cytoreductive nephrectomy (CN).
    Cunha, Mateus Trinconi
    Stangler, Lucas
    Freire, Pedro
    Alves Pinto, Paulo Victor
    Almeida Coelho, Fernando Morbeck
    Viana, Publio
    Cordeiro, Mauricio
    Nahas, William Carlos
    Mota, Jose Mauricio
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [25] Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma CON
    McKiernan, James
    JOURNAL OF UROLOGY, 2013, 190 (02) : 386 - 386
  • [26] Metastatic Renal Cell Carcinoma Is Cytoreductive Nephrectomy Beneficial?
    Bedke, Jens
    Kruck, Stephan
    AKTUELLE UROLOGIE, 2015, 46 (06) : 429 - 429
  • [27] Laparoscopic cytoreductive nephrectomy for metastatic renal cell carcinoma
    Finelli, A
    Kaouk, JH
    Fergany, AF
    Abreu, SC
    Novick, AC
    Gill, IS
    BJU INTERNATIONAL, 2004, 94 (03) : 291 - 294
  • [28] Cytoreductive nephrectomy in metastatic renal cell carcinoma (Review)
    Dahm, Philipp
    Ergun, Onuralp
    Uhlig, Annemarie
    Bellut, Laura
    Risk, Michael C.
    Lyon, Jennifer A.
    Kunath, Frank
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2024, (06):
  • [29] Sunitinib and Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma
    Bajic, Petar
    Flanigan, Robert C.
    Joyce, Cara J.
    Clark, Joseph I.
    JOURNAL OF UROLOGY, 2019, 201 (03) : 453 - 454
  • [30] Cytoreductive nephrectomy for metastatic renal cell carcinoma – obsolete?
    Grimm M.-O.
    Der Urologe, 2019, 58 (1): : 51 - 52
12345